- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/18 - Bridged systems
Patent holdings for IPC class C07D 487/18
Total number of patents in this class: 358
10-year publication summary
|
20
|
26
|
17
|
22
|
20
|
19
|
23
|
25
|
29
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi | 4297 |
27 |
| Bristol-myers Squibb Company | 4721 |
24 |
| UCB Biopharma SRL | 597 |
12 |
| Demerx, Inc. | 76 |
11 |
| Merck Patent GmbH | 5725 |
10 |
| Gilead Sciences, Inc. | 2219 |
7 |
| UCB Biopharma SPRL | 334 |
7 |
| Janssen Pharmaceutica N.V. | 3177 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
6 |
| F. Hoffmann-La Roche AG | 7832 |
5 |
| Oncodesign S.A. | 16 |
5 |
| Sunovion Pharmaceuticals Inc. | 244 |
5 |
| Pathios Therapeutics Limited | 30 |
5 |
| Merck Sharp & Dohme LLC | 3728 |
5 |
| Forward Therapeutics, Inc. | 21 |
5 |
| Abbott Laboratories | 2259 |
4 |
| Bayer Pharma AG | 1015 |
4 |
| Achillion Pharmaceuticals, Inc. | 158 |
4 |
| Ecolab USA Inc. | 5795 |
4 |
| Lumiphore, Inc. | 35 |
4 |
| Other owners | 198 |